Areas of Interest
Pancreatic cancer is the deadliest major cancer, with a 5-year survival rate of only 10%. My research project focuses on the metabolic and immunological processes that occur in the tumor microenvironment that contribute to the pernicious effect that pancreatic cancer has on patients. Specifically, I am investigating the interplay between hypoxia-inducible factors (HIFs), macrophages, and cancer cells. By better understanding the cross-talk between these cells and surrounding molecules, cancer researchers can work to develop targeted therapies for patients with this devastating disease.